ArticleBlood advances2022

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy.

Sushanth Gouni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.